Gene and Genome Editing represent ground-breaking technologies that enable precise modifications to the genetic material of organisms. These technologies have revolutionized various fields, including biomedicine, agriculture, and biotechnology, by offering unprecedented opportunities for manipulating DNA sequences with high efficiency and accuracy. Gene editing involves making targeted modifications to specific genes within an organism's genome. This is typically achieved using programmable nucleases, such as CRISPR-Cas9, zinc finger nucleases (ZFNs), or transcription activator-like effector nucleases (TALENs), which can be engineered to recognize and cleave specific DNA sequences. Once the DNA is cleaved, the cell's natural repair mechanisms, such as non-homologous end joining (NHEJ) or homology-directed repair (HDR), can be exploited to introduce desired genetic changes. Genome editing, on the other hand, involves making modifications to the entire genome of an organism. This can include large-scale alterations, such as chromosomal rearrangements or deletions, as well as precise modifications to multiple genes simultaneously. Genome editing technologies offer powerful tools for studying gene function, genetic pathways, and complex traits in various organisms, from model organisms like mice and fruit flies to agriculturally important crops and livestock species.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy